Trade Name: Anastrozol
Substance: Arimidex
Country of Production: Ratiopharm, EU
Form: 1 mg / tbl.
ARIMIDEX is indicated for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
ARIMIDEX is indicated for the first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.
ARIMIDEX is indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy .
Our Price: $70.00
Availability: OK

Quantity:
$70.00
Trade Name: Anastrozol
Substance: Arimidex
Country of Production: Ratiopharm, EU
Form: 1 mg / tbl.
ARIMIDEX is indicated for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
ARIMIDEX is indicated for the first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.
ARIMIDEX is indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy .
There are currently no product reviews.